How much of the 1998 earnings growth came from underlying operations versus one-time items and investment gains?

Income excluding net realized gains and non-recurring expenses rose 9.8% to $418.4 million from $381.1 million, a more modest rate than headline net income growth. Net realized gains of $188.4 million (versus $127.7 million in 1997) are non-recurring in nature and were driven largely by equity securities sales, while $46.6 million of non-recurring transaction expenses reduced earnings. Investors should focus on the recurring figure when evaluating sustainable earnings power.

Why did the expense ratio rise so sharply in 1998?

The underwriting and administrative expense ratio increased to 30.4% from 19.0%. About 5.4 percentage points reflect non-recurring transaction expenses, and the remainder reflects the inclusion of ACE USA and CAT Limited, which carry higher expense ratios than the traditional Bermuda book, plus higher costs from expanded Lloyd's participation. Management characterizes the ratio as structurally higher going forward for the newly acquired businesses.

How is the company financing its acquisitions, and what are the debt implications?

The company used $385 million of short-term bank debt to fund the CAT acquisition, repaid largely from the April 1998 equity offering. The $250 million ACE USA term loan was refinanced in October 1998 with 8.63% senior notes due 2008, and a $250 million credit default swap reduces the effective cost of that debt to about 6.47% for 10 years. Bank facilities include $400 million of unsecured revolving credit and Lloyd's letter-of-credit facilities, and debt covenants include tangible net worth and leverage tests.

What are the main risks that could affect future results?

Key risks include the uncertainty of loss reserves for long-tail excess liability lines, potential catastrophic events exceeding estimates in the property catastrophe reinsurance book, ongoing soft pricing across most insurance and reinsurance markets, and unresolved breast implant litigation with possible additional reserve needs. The company also faces tax-related risk: its Cayman and Bermuda tax exemptions could be challenged, and U.S. state premium tax or income tax disputes could materially affect shareholders' equity and earnings.

What is the outlook for capital returns to shareholders?

The company paid $0.34 per share in dividends for fiscal 1998, up from $0.27, and declared a quarterly dividend of $0.09 per share in November 1998. Share repurchases totaled $107.6 million in the first half of fiscal 1998, and all repurchase authorizations were rescinded on July 6, 1998, so buybacks are no longer authorized. Future dividends remain at the Board's discretion and depend on profits, financial requirements, and legal restrictions on subsidiary dividend payments.

CB 10-K FY1998 Annual Report — Revenue, Net Income, EPS

01—Abstract

Summary

Summary of the 10-K filed December 18, 1998. Cited figures are marked; the original filing is the authoritative source.

ACE Limited (NYSE: ACL, referred to in the filing as CB context aside) reported fiscal year ended September 30, 1998 results that show strong top-line and investment growth, driven largely by acquisitions.

Gross premiums written rose 29.5% to $1,242.2 million^a, and net premiums earned rose 11.1% to $894.3 million. Net income was $560.2 million, up 11.5% from $502.7 million, or $2.96 diluted EPS. However, the headline figure is flattered by $46.6 million of non-recurring transaction expenses, and the combined ratio deteriorated to 88.2% from 79.4%, partly due to these charges and the integration of higher-expense Lloyd's and ACE USA operations.

Excluding non-recurring items, the underwriting and administrative expense ratio would have been 25.0%, versus 18.3% in 1997. The balance sheet expanded materially: total assets reached $8.8 billion, shareholders' equity rose to $3.71 billion^b (book value per share $19.19, fully diluted $19.14), and total investments and cash grew to $6.2 billion. Growth was financed through the $606 million April 1998 share offering, $385 million of bank debt used to buy CAT Limited (later repaid), and a $250 million term loan refinanced by 8.63% senior notes in October 1998.

Net realized gains of $188.4 million^c, largely from equity sales, contributed meaningfully to pre-tax income, so investors should separate recurring underwriting and investment income from realized gains when assessing earnings quality. Key risks flagged in the filing include reserving uncertainty (gross unpaid losses and loss expenses of $3.7 billion, with a large IBNR component), continuing soft market pricing in property catastrophe and excess liability lines, the unresolved breast implant litigation, potential U.S. income tax exposure if the company's Cayman/Bermuda structure is challenged, and state premium tax challenges. The company is a Cayman Islands holding company with Bermuda-based operations and tax exemptions that run through 2013 (Cayman) and 2016 (Bermuda), which investors should weigh against the regulatory and tax-policy risks described in the filing.

02—Key points

Key Highlights

Gross premiums written grew 29.5% to $1,242.2 million, mainly from nine months of ACE USA and six months of CAT Limited following their 1998 acquisitions, plus higher Lloyd's syndicate participation.
Net income rose to $560.2 million ($2.96 diluted EPS) from $502.7 million, but included $46.6 million of non-recurring transaction-related expenses and $188.4 million of net realized investment gains.
Combined ratio worsened to 88.2% from 79.4%, driven by a 30.4% underwriting and administrative expense ratio (25.0% excluding non-recurring items) versus 18.3% in 1997.
Shareholders' equity increased to $3.71 billion (book value $19.19 per share) from $2.79 billion, aided by the April 1998 sale of 16.5 million shares for about $606 million net.
Total assets reached $8.8 billion, with investments and cash of $6.2 billion, up from $4.8 billion, reflecting acquired portfolios of ACE USA and CAT Limited.
Gross unpaid losses and loss expenses of $3.74 billion, including $2.33 billion of IBNR, carry significant reserving uncertainty given the long-tail, high-severity excess liability book.
Major acquisitions in 1998 included ACE USA ($338 million cash), CAT Limited (about $641 million cash), and Tarquin Limited (pooling-of-interests), with National Indemnity providing $750 million of reinsurance protection to ACE USA.

03—Questions

Frequently Asked Questions

How much of the 1998 earnings growth came from underlying operations versus one-time items and investment gains?
Income excluding net realized gains and non-recurring expenses rose 9.8% to $418.4 million from $381.1 million, a more modest rate than headline net income growth. Net realized gains of $188.4 million (versus $127.7 million in 1997) are non-recurring in nature and were driven largely by equity securities sales, while $46.6 million of non-recurring transaction expenses reduced earnings. Investors should focus on the recurring figure when evaluating sustainable earnings power.
Why did the expense ratio rise so sharply in 1998?
The underwriting and administrative expense ratio increased to 30.4% from 19.0%. About 5.4 percentage points reflect non-recurring transaction expenses, and the remainder reflects the inclusion of ACE USA and CAT Limited, which carry higher expense ratios than the traditional Bermuda book, plus higher costs from expanded Lloyd's participation. Management characterizes the ratio as structurally higher going forward for the newly acquired businesses.
How is the company financing its acquisitions, and what are the debt implications?
The company used $385 million of short-term bank debt to fund the CAT acquisition, repaid largely from the April 1998 equity offering. The $250 million ACE USA term loan was refinanced in October 1998 with 8.63% senior notes due 2008, and a $250 million credit default swap reduces the effective cost of that debt to about 6.47% for 10 years. Bank facilities include $400 million of unsecured revolving credit and Lloyd's letter-of-credit facilities, and debt covenants include tangible net worth and leverage tests.
What are the main risks that could affect future results?
Key risks include the uncertainty of loss reserves for long-tail excess liability lines, potential catastrophic events exceeding estimates in the property catastrophe reinsurance book, ongoing soft pricing across most insurance and reinsurance markets, and unresolved breast implant litigation with possible additional reserve needs. The company also faces tax-related risk: its Cayman and Bermuda tax exemptions could be challenged, and U.S. state premium tax or income tax disputes could materially affect shareholders' equity and earnings.
What is the outlook for capital returns to shareholders?
The company paid $0.34 per share in dividends for fiscal 1998, up from $0.27, and declared a quarterly dividend of $0.09 per share in November 1998. Share repurchases totaled $107.6 million in the first half of fiscal 1998, and all repurchase authorizations were rescinded on July 6, 1998, so buybacks are no longer authorized. Future dividends remain at the Board's discretion and depend on profits, financial requirements, and legal restrictions on subsidiary dividend payments.

04—Continue

← View all 10-K filings